Last reviewed · How we verify
Placebo of N-acetylcysteine — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of N-acetylcysteine (Placebo of N-acetylcysteine) — University Hospital, Lille. This is a placebo control arm with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of N-acetylcysteine TARGET | Placebo of N-acetylcysteine | University Hospital, Lille | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of N-acetylcysteine CI watch — RSS
- Placebo of N-acetylcysteine CI watch — Atom
- Placebo of N-acetylcysteine CI watch — JSON
- Placebo of N-acetylcysteine alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of N-acetylcysteine — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-n-acetylcysteine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab